Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meir Wetzler

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
Annals of Hematology|September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
Haematologica|October 8, 2013
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classificationMeir Wetzler, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.
Leukemia Research|March 5, 2016
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemiaElizabeth A Griffiths, William E Brady, Wei Tan, et al.
Journal of Clinical Microbiology|April 9, 2004
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipientImad Dibo, Satish K Pillai, Howard S Gold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemiaGeorge L Chen, Hong Liu, Yali Zhang, et al.
Mycopathologia|March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristicsAasma Shaukat, Faris Bakri, Paul Young, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
International Journal of Cancer|April 27, 2011
Smoking adversely affects survival in acute myeloid leukemia patientsRamya Varadarajan, Andrea S Licht, Andrew J Hyland, et al.
Genes, Chromosomes & Cancer|August 5, 2005
Genomic profiling of myeloid sarcoma by array comparative genomic hybridizationGeorge Deeb, Maria R Baer, Daniel P Gaile, et al.
Annals of Hematology|September 22, 2011
Is obesity a prognostic factor for acute myeloid leukemia outcome?Hun Ju Lee, Andrea S Licht, Andrew J Hyland, et al.
Haematologica|October 8, 2013
Intensive induction is effective in selected octogenarian acute myeloid leukemia patients: prognostic significance of karyotype and selected molecular markers used in the European LeukemiaNet classificationMeir Wetzler, Krzysztof Mrózek, Jessica Kohlschmidt, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|February 22, 2011
NCCN Task Force report: tyrosine kinase inhibitor therapy selection in the management of patients with chronic myelogenous leukemiaSusan O'Brien, Ellin Berman, Joseph O Moore, et al.
Cancer|April 2, 2011
Phase 1 study of arsenic trioxide, high-dose cytarabine, and idarubicin to down-regulate constitutive signal transducer and activator of transcription 3 activity in patients aged <60 years with acute myeloid leukemiaMeir Wetzler, Chris Andrews, Laurie A Ford, et al.
Leukemia Research|March 5, 2016
A phase I study of intermediate dose cytarabine in combination with lenalidomide in relapsed/refractory acute myeloid leukemiaElizabeth A Griffiths, William E Brady, Wei Tan, et al.
Journal of Clinical Microbiology|April 9, 2004
Linezolid-resistant Enterococcus faecalis isolated from a cord blood transplant recipientImad Dibo, Satish K Pillai, Howard S Gold, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 29, 2014
Early versus late preemptive allogeneic hematopoietic cell transplantation for relapsed or refractory acute myeloid leukemiaGeorge L Chen, Hong Liu, Yali Zhang, et al.
Mycopathologia|March 17, 2005
Invasive filamentous fungal infections in allogeneic hematopoietic stem cell transplant recipients after recovery from neutropenia: clinical, radiologic, and pathologic characteristicsAasma Shaukat, Faris Bakri, Paul Young, et al.
Pageof 12